Estrogen receptor modulators

The specification relates to compounds of Formula (I): (I) 5and to pharmaceutically acceptable salts thereof, to processes and intermediates used for their preparation, to pharmaceutical compositions containing them and to their use in the treatment of cell proliferative disorders.

Saved in:
Bibliographic Details
Main Authors Nissink, Johannes Wilhelmus Maria, Barlaam, Bernard Christophe, Scott, James Stewart, Moss, Thomas Andrew, Yang, Bin, Hughes, Samantha Jayne
Format Patent
LanguageEnglish
Published 12.09.2019
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The specification relates to compounds of Formula (I): (I) 5and to pharmaceutically acceptable salts thereof, to processes and intermediates used for their preparation, to pharmaceutical compositions containing them and to their use in the treatment of cell proliferative disorders.
Bibliography:Application Number: AU20180211495